143 related articles for article (PubMed ID: 34957890)
1. Loss of function mutations of
Giefing M; Gearhart MD; Schneider M; Overbeck B; Klapper W; Hartmann S; Ustaszewski A; Weniger MA; Wiehle L; Hansmann ML; Melnick A; Béguelin W; Sundström C; Küppers R; Bardwell VJ; Siebert R
Leuk Lymphoma; 2022 May; 63(5):1080-1090. PubMed ID: 34957890
[TBL] [Abstract][Full Text] [Related]
2. A Non-canonical BCOR-PRC1.1 Complex Represses Differentiation Programs in Human ESCs.
Wang Z; Gearhart MD; Lee YW; Kumar I; Ramazanov B; Zhang Y; Hernandez C; Lu AY; Neuenkirchen N; Deng J; Jin J; Kluger Y; Neubert TA; Bardwell VJ; Ivanova NB
Cell Stem Cell; 2018 Feb; 22(2):235-251.e9. PubMed ID: 29337181
[TBL] [Abstract][Full Text] [Related]
3. OFCD syndrome and extraembryonic defects are revealed by conditional mutation of the Polycomb-group repressive complex 1.1 (PRC1.1) gene BCOR.
Hamline MY; Corcoran CM; Wamstad JA; Miletich I; Feng J; Lohr JL; Hemberger M; Sharpe PT; Gearhart MD; Bardwell VJ
Dev Biol; 2020 Dec; 468(1-2):110-132. PubMed ID: 32692983
[TBL] [Abstract][Full Text] [Related]
4. Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma.
Tiacci E; Döring C; Brune V; van Noesel CJ; Klapper W; Mechtersheimer G; Falini B; Küppers R; Hansmann ML
Blood; 2012 Nov; 120(23):4609-20. PubMed ID: 22955914
[TBL] [Abstract][Full Text] [Related]
5. BCOR involvement in cancer.
Astolfi A; Fiore M; Melchionda F; Indio V; Bertuccio SN; Pession A
Epigenomics; 2019 May; 11(7):835-855. PubMed ID: 31150281
[No Abstract] [Full Text] [Related]
6. Coexpression of BMI-1 and EZH2 polycomb group genes in Reed-Sternberg cells of Hodgkin's disease.
Raaphorst FM; van Kemenade FJ; Blokzijl T; Fieret E; Hamer KM; Satijn DP; Otte AP; Meijer CJ
Am J Pathol; 2000 Sep; 157(3):709-15. PubMed ID: 10980109
[TBL] [Abstract][Full Text] [Related]
7. Rare occurrence of biallelic CYLD gene mutations in classical Hodgkin lymphoma.
Schmidt A; Schmitz R; Giefing M; Martin-Subero JI; Gesk S; Vater I; Massow A; Maggio E; Schneider M; Hansmann ML; Siebert R; Küppers R
Genes Chromosomes Cancer; 2010 Sep; 49(9):803-9. PubMed ID: 20607853
[TBL] [Abstract][Full Text] [Related]
8. KDM2B in polycomb repressive complex 1.1 functions as a tumor suppressor in the initiation of T-cell leukemogenesis.
Isshiki Y; Nakajima-Takagi Y; Oshima M; Aoyama K; Rizk M; Kurosawa S; Saraya A; Kondo T; Sakaida E; Nakaseko C; Yokote K; Koseki H; Iwama A
Blood Adv; 2019 Sep; 3(17):2537-2549. PubMed ID: 31471323
[TBL] [Abstract][Full Text] [Related]
9. Hodgkin-Reed-Sternberg cells in classical Hodgkin lymphoma show alterations of genes encoding the NADPH oxidase complex and impaired reactive oxygen species synthesis capacity.
Giefing M; Winoto-Morbach S; Sosna J; Döring C; Klapper W; Küppers R; Böttcher S; Adam D; Siebert R; Schütze S
PLoS One; 2013; 8(12):e84928. PubMed ID: 24376854
[TBL] [Abstract][Full Text] [Related]
10. Occurrence of minimal change nephrotic syndrome in classical Hodgkin lymphoma is closely related to the induction of c-mip in Hodgkin-Reed Sternberg cells and podocytes.
Audard V; Zhang SY; Copie-Bergman C; Rucker-Martin C; Ory V; Candelier M; Baia M; Lang P; Pawlak A; Sahali D
Blood; 2010 May; 115(18):3756-62. PubMed ID: 20200355
[TBL] [Abstract][Full Text] [Related]
11. Structure and Role of BCOR PUFD in Noncanonical PRC1 Assembly and Disease.
Wong SJ; Senkovich O; Artigas JA; Gearhart MD; Ilangovan U; Graham DW; Abel KN; Yu T; Hinck AP; Bardwell VJ; Kim CA
Biochemistry; 2020 Jul; 59(29):2718-2728. PubMed ID: 32628469
[TBL] [Abstract][Full Text] [Related]
12. Typing the histogenetic origin of the tumor cells of lymphocyte-rich classical Hodgkin's lymphoma in relation to tumor cells of classical and lymphocyte-predominance Hodgkin's lymphoma.
Bräuninger A; Wacker HH; Rajewsky K; Küppers R; Hansmann ML
Cancer Res; 2003 Apr; 63(7):1644-51. PubMed ID: 12670918
[TBL] [Abstract][Full Text] [Related]
13. BCOR regulates myeloid cell proliferation and differentiation.
Cao Q; Gearhart MD; Gery S; Shojaee S; Yang H; Sun H; Lin DC; Bai JW; Mead M; Zhao Z; Chen Q; Chien WW; Alkan S; Alpermann T; Haferlach T; Müschen M; Bardwell VJ; Koeffler HP
Leukemia; 2016 May; 30(5):1155-65. PubMed ID: 26847029
[TBL] [Abstract][Full Text] [Related]
14. Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77+ B-cells reveals a distinct subset of differentially expressed miRNAs.
Van Vlierberghe P; De Weer A; Mestdagh P; Feys T; De Preter K; De Paepe P; Lambein K; Vandesompele J; Van Roy N; Verhasselt B; Poppe B; Speleman F
Br J Haematol; 2009 Dec; 147(5):686-90. PubMed ID: 19775296
[TBL] [Abstract][Full Text] [Related]
15. Profiling of Hodgkin's lymphoma cell line L1236 and germinal center B cells: identification of Hodgkin's lymphoma-specific genes.
Schwering I; Bräuninger A; Distler V; Jesdinsky J; Diehl V; Hansmann ML; Rajewsky K; Küppers R
Mol Med; 2003; 9(3-4):85-95. PubMed ID: 12865944
[TBL] [Abstract][Full Text] [Related]
16. Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3), which promotes viability of Hodgkin/Reed-Sternberg cells.
Janz M; Hummel M; Truss M; Wollert-Wulf B; Mathas S; Jöhrens K; Hagemeier C; Bommert K; Stein H; Dörken B; Bargou RC
Blood; 2006 Mar; 107(6):2536-9. PubMed ID: 16263788
[TBL] [Abstract][Full Text] [Related]
17. Analysis of BCL-6 mutations in classic Hodgkin disease of the B- and T-cell type.
Seitz V; Hummel M; Anagnostopoulos I; Stein H
Blood; 2001 Apr; 97(8):2401-5. PubMed ID: 11290603
[TBL] [Abstract][Full Text] [Related]
18. Evidence of abortive plasma cell differentiation in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma.
Buettner M; Greiner A; Avramidou A; Jäck HM; Niedobitek G
Hematol Oncol; 2005; 23(3-4):127-32. PubMed ID: 16342298
[TBL] [Abstract][Full Text] [Related]
19. Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation.
Weniger MA; Melzner I; Menz CK; Wegener S; Bucur AJ; Dorsch K; Mattfeldt T; Barth TF; Möller P
Oncogene; 2006 Apr; 25(18):2679-84. PubMed ID: 16532038
[TBL] [Abstract][Full Text] [Related]
20. Suppressor of cytokine signaling 1 gene mutation status as a prognostic biomarker in classical Hodgkin lymphoma.
Lennerz JK; Hoffmann K; Bubolz AM; Lessel D; Welke C; Rüther N; Viardot A; Möller P
Oncotarget; 2015 Oct; 6(30):29097-110. PubMed ID: 26336985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
